Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,797Revenue (TTM) $M757Net Margin (%)4.3Altman Z-Score2.9
Enterprise Value $M1,792EPS (TTM) $0.5Operating Margin %9.0Piotroski F-Score4
P/E(ttm)58.6Beneish M-Score-3.4Pre-tax Margin (%)8.1Higher ROA y-yN
Price/Book2.410-y EBITDA Growth Rate %--Quick Ratio1.4Cash flow > EarningsY
Price/Sales2.45-y EBITDA Growth Rate %6.2Current Ratio1.6Lower Leverage y-yN
Price/Free Cash Flow18.4y-y EBITDA Growth Rate %-43.0ROA % (ttm)2.9Higher Current Ratio y-yN
Dividend Yield %--PEG9.5ROE % (ttm)4.3Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M68.1ROIC % (ttm)4.9Gross Margin Increase y-yN

Gurus Latest Trades with MYGN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

MYGN is held by these investors:

MYGN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HENDERSON JOHN TDirector 2017-02-23Buy6,000$18.6641.43view
HENDERSON JOHN TDirector 2016-09-12Sell30,000$20.4928.79view
Capone Mark ChristopherPresident & C.E.O. 2016-08-19Buy10,000$21.2424.25view
McDade Ralph LPresident Myriad RBM, Inc. 2016-08-12Buy1,000$21.4922.8view
Ford AlexanderPresident, MGL 2016-06-21Sell18,637$30.87-14.51view
King Gary A.Exec. VP International Ops 2016-04-06Sell15,000$39.03-32.39view
King Gary A.Exec. VP International Ops 2016-04-01Sell15,000$38.12-30.77view
GILBERT WALTER PHDDirector 2015-12-11Sell5,000$42.23-37.51view
Phanstiel S. LouiseDirector 2015-12-08Sell5,000$44-40.02view
DREISMANN HEINRICHDirector 2015-11-05Sell60,000$44.44-40.62view

Press Releases about MYGN :

Quarterly/Annual Reports about MYGN:

News about MYGN:

Articles On GuruFocus.com
Boeing Takes Lead Over Airbus With $30 Billion Worth of Orders on Day 1 of Paris Air Show Jun 25 2017 
Berkshire Hathaway’s Recent Investment: Home Capital Group Jun 25 2017 
Stocks That Fell to 3-Year Lows in the Week of June 23 Jun 24 2017 
Weekly Top Insider Buys Highlight for the Week of June 23 Jun 24 2017 
ID Watchdog Announces Special and Annual General Meeting Date and Record Date Jun 23 2017 
Ironclad Performance Wear Postpones 2017 Annual Meeting of Stockholders Jun 23 2017 
Delta and Korean Air Create Leading trans-Pacific Joint Venture Jun 23 2017 
Harwood Feffer LLP Announces Investigation of EnerNOC, Inc. Jun 23 2017 
Charles D. Christy Named Chief Financial Officer Jun 23 2017 
Harwood Feffer LLP Announces Investigation of CardConnect Corp. Jun 23 2017 

More From Other Websites
Myriad Genetics (MYGN) Catches Eye: Stock Moves Up 5.7% Jun 22 2017
Virginia C. Drosos, President of Assurex Health, Receives the EY Entrepreneur of the Year 2017... Jun 19 2017
Crescendo Bioscience Announces Results from a Meta-Analysis of Studies with Vectra® DA at the 2017... Jun 15 2017
Crescendo Bioscience Announces Six Studies with Vectra® DA Will Be Presented at the 2017 Annual... Jun 08 2017
Myriad Genetics BRACAnalysis CDx in OlympiAD Results Positive Jun 05 2017
Why Is Myriad Genetics (MYGN) Down 9.6% Since the Last Earnings Report? Jun 05 2017
Myriad’s BRACAnalysis CDx® Test Identified Patients with Metastatic Breast Cancer Who Benefited... Jun 04 2017
Myriad Announces 17 Additional Health Insurance Plans Covering EndoPredict™ Jun 02 2017
ETFs with exposure to Myriad Genetics, Inc. : June 2, 2017 Jun 02 2017
Myriad Genetics Announces Results from a Large 2,000 Patient Clinical Utility Study of Its myRisk®... Jun 02 2017
Myriad Genetics to Present at the 2017 William Blair Growth Stock Conference May 31 2017
Myriad Genetics to Present at the 2017 Goldman Sachs Global Healthcare Conference May 30 2017
Myriad Genetics Gets Extended Coverage for Prolaris Test May 29 2017
Medicare Coverage of Prolaris® Test Expands with the Addition of Men Diagnosed with Favorable... May 25 2017
Edited Transcript of MYGN earnings conference call or presentation 2-May-17 8:30pm GMT May 23 2017
ETFs with exposure to Myriad Genetics, Inc. : May 22, 2017 May 22 2017
Myriad Genetics to Present Seven Studies at the 2017 American Society of Clinical Oncology Annual... May 18 2017
Myriad Genetics’ Prolaris® Test Accurately Predicts the 10-Year Risk of Metastases in Men Treated... May 12 2017
Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: Q3, 2017 By the Numbers : May 8, 2017 May 08 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat